Mediplius, UAB - financials and debts

Company age: 9 y. 3 mo.

Update

Mediplius - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 3,643 27,595 44,138 102,520 118,865 213,183 234,083 214,313
Profit before tax -1,278 1,062 13,507 22,229 -8,167 17,936 14,859 13,970
Net profit -1,278 900 12,830 21,065 -8,167 17,936 14,035 13,132
Equity -550 -2,753 10,077 31,142 22,974 40,910 54,945 68,077
Liabilities 3,054 16,952 19,982 24,344 22,121 42,663 53,154 67,000
Non-current assets 0 0 0 0 0 0 0 0
Current assets 2,504 14,199 30,059 55,486 45,095 83,312 107,918 134,907
Total assets 2,504 14,199 30,059 55,486 45,095 83,312 107,918 134,907
Taxes paid
STI taxes - - - - - 12,791 12,665 10,950
Social insurance contributions - - - - - - - 5,083
Financial indicators
Revenue change y/y +385.7% +657.5% +59.9% +132.3% +15.9% +79.3% +9.8% -8.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -51.0% 6.3% 42.7% 38.0% -18.1% 21.5% 13.0% 9.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - 127.3% 67.6% -35.5% 43.8% 25.5% 19.3%
Profit margin Net profit margin. Shows the overall profitability of the company. -35.1% 3.3% 29.1% 20.5% -6.9% 8.4% 6.0% 6.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -35.1% 3.8% 30.6% 21.7% -6.9% 8.4% 6.3% 6.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - 2.0 0.8 1.0 1.0 1.0 1.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 5,464 19,711 18,917 34,173 39,622 71,061 78,028 64,295

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Mediplius - Social security debts

From To Debt, €
2026-06-17 2026-06-29 0.99
2026-06-16 2026-06-16 1279.65
2026-06-11 2026-06-15 0.99
2026-05-17 2026-06-08 0.99
2026-05-03 2026-05-12 0.99
2026-04-24 2026-04-29 0.99
2026-03-27 2026-03-27 4.56
2026-03-17 2026-03-25 4.56
2026-02-19 2026-03-11 4.56
2026-02-18 2026-02-18 1283.22
2026-01-22 2026-02-17 4.56
2025-12-16 2025-12-17 1278.66
2025-11-18 2025-11-27 1244.25
2025-09-16 2025-09-16 852.31
2025-07-16 2025-07-20 848.46
2025-04-16 2025-04-16 820.16
2024-12-17 2024-12-20 658.01
2024-10-16 2024-10-17 659.51
2024-05-16 2024-05-19 659.16
2024-04-16 2024-04-16 658.17
2024-03-18 2024-03-18 658.17
2023-10-25 2023-12-11 0.86
2023-08-17 2023-08-20 504.02
2023-07-28 2023-08-16 0.24
2023-07-24 2023-07-25 0.27
2023-06-16 2023-06-18 498.09
2023-05-16 2023-05-16 498.69
2022-10-28 2022-11-08 0.78
2022-10-18 2022-10-18 504.46
2022-09-20 2022-09-26 19.61
2022-09-16 2022-09-19 494.40
2022-04-28 2022-05-12 0.26
2022-03-16 2022-03-16 434.50

Mediplius - VMI tax arrears

From To Overdue, €
2025-07-28 2025-07-28 235.2
2025-07-01 2025-07-01 214.14
2025-06-28 2025-06-30 213.99
2025-03-05 2025-03-20 0.03
2025-03-02 2025-03-04 27.19
2025-02-28 2025-03-01 27.16
2025-02-20 2025-02-27 0.16
2025-02-05 2025-02-19 0.08
2025-02-02 2025-02-04 87.49
2025-01-30 2025-02-01 87.41

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Mediplius, UAB (company code 304545759) is a Private Limited Liability Company operating in other non-specialised retail sale. In the latest financial year 2025, the company generated revenue of €214.3K and net profit of €13.1K, with a profit margin of 6.1%. Revenue declined by 8.4% year on year from €234.1K in 2024, but the two-year comparison shows broadly stable turnover, up 0.5% versus 2023, when revenue was €213.2K. Profitability eased from €17.9K in 2023 and €14.0K in 2024 to €13.1K in 2025, indicating a moderate downward trend in earnings despite continued positive results. The balance sheet expanded over the period, with total assets increasing from €83.3K in 2023 to €107.9K in 2024 and €134.9K in 2025. Equity also strengthened from €40.9K to €54.9K and then to €68.1K, while liabilities rose from €42.7K to €67.0K. For 2025, ROE was 19.3%, ROA 9.7%, debt-to-equity 0.98, and asset turnover 1.59x. Revenue per employee was €71.4K and profit per employee €4.4K.